Wells Fargo & Company »

Cue Biopharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $820 26 31.58

More positions owned by Wells Fargo & Company

Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
JPMorgan Chase & Co. (JPM)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma